Hair loss. Nonscarring hair loss, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In one group, PRP will be given as an injection in two sessions one month apart. Intervention 2: Intervention group: In one group, they will receive PRP with micron
Sponsors
Skin and Stem Cell Research Center, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Platelet disorders, thrombocytopenia, patients receiving anticoagulants, patients with malignancy, receiving chemotherapy in the last 5 years, patients with sepsis, smoking, pregnancy, ulcers or active infections at the treatment site, not receiving any topical or systemic drugs In the last 3 months, women with hyperprolactinemia, women with hormonal disorders or polycystic ovaries
Exclusion criteria
Exclusion criteria: Dissatisfaction with continuing treatment for any reason, lack of follow-up, severe allergic reaction to the injection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of hair loss. Timepoint: Before treatment and two month after the last session. Method of measurement: Trichoscan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: One week after session. Method of measurement: Questionnaire and visit.;Satisfaction. Timepoint: Two months after the last session. Method of measurement: Questionnaire and visit.;Tolerability. Timepoint: Each session after transplantation. Method of measurement: Questionnaire and visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and stem Cell Research Center, Tehran University of Medical Sciences
Outcome results
None listed